Title : Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).

Pub. Date : 2021 Sep

PMID : 33932130






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Exposure of drugs that are CYP3A4 substrates is likely to decrease when coadministered with dabrafenib. dabrafenib cytochrome P450 family 3 subfamily A member 4 Homo sapiens